Vasculitic presentation of staphylococcal meningitis.
Bentley
Paul
P
St Mary's Hospital, Praed St, London, UK. p.bentley@fil.ion.ucl.ac.uk
Qadri
Farzana
F
Wild
Edward J
EJ
Hirsch
Nicholas P
NP
Howard
Robin S
RS
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005436:Floxacillin / Q000008:administration & dosage / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D016920:Meningitis, Bacterial / Q000150:complications* / Q000473:pathology; D008775:Methylprednisolone / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000150:complications* / Q000473:pathology; D014657:Vasculitis / Q000209:etiology*
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D005839:Gentamicins; D005436:Floxacillin; D002443:Ceftriaxone; D003907:Dexamethasone; D012293:Rifampin; D008775:Methylprednisolone